Rosuvastatin 5 mg efficacy
Pro Research Analysisby 
Searched over 200M research papers
Rosuvastatin 5 mg Efficacy in Lowering LDL-C and Improving Lipid Profiles
Multiple studies show that rosuvastatin 5 mg is highly effective in lowering low-density lipoprotein cholesterol (LDL-C) across a range of patient populations, including those with diabetes, hypercholesterolemia, and high cardiovascular risk. Mean reductions in LDL-C with rosuvastatin 5 mg range from 39% to 52% in various studies, with many patients achieving recommended LDL-C targets Teramoto2005Ullah2015Kurabayashi2008+4 MORE. In addition to LDL-C, rosuvastatin 5 mg also lowers total cholesterol, triglycerides, non-HDL cholesterol, and apolipoprotein B, while increasing high-density lipoprotein cholesterol (HDL-C) Teramoto2005Meek2012Laffin2022+2 MORE.
Comparison with Other Statins and Doses
When compared to other statins, rosuvastatin 5 mg often produces greater reductions in LDL-C and larger increases in HDL-C than initial doses of atorvastatin, simvastatin, or pravastatin Teramoto2005Kurabayashi2008Rehman2020+2 MORE. In head-to-head studies, rosuvastatin 5 mg was more effective than simvastatin 20 mg and atorvastatin 10 mg in reducing LDL-C, and more patients achieved LDL-C goals with rosuvastatin 5 mg Kurabayashi2008Rehman2020Zhao2018. In patients with type 2 diabetes, rosuvastatin 5 mg was as effective as 10 mg in reducing LDL-C, suggesting that the lower dose can be sufficient for many patients Ullah2015Aleem2022Shah2013.
Efficacy in Special Populations and Statin-Intolerant Patients
Rosuvastatin 5 mg is effective in a wide range of patients, including the elderly, obese, postmenopausal women, and those with hypertension, coronary heart disease, diabetes, and metabolic syndrome Teramoto2005Meek2012Ullah2015+1 MORE. In statin-intolerant patients, daily or intermittent dosing of rosuvastatin 5 mg still resulted in significant reductions in LDL-C, total cholesterol, and triglycerides, with good tolerability and adherence .
Safety and Tolerability of Rosuvastatin 5 mg
Across studies, rosuvastatin 5 mg is generally well tolerated, with adverse event rates similar to those of other statins and placebo Meek2012Laffin2022Aleem2022+2 MORE. The incidence of muscle-related side effects is low and not significantly different from higher doses or other statins Meek2012Aleem2022Shah2013. Liver enzyme and creatine kinase levels remain stable during treatment .
Conclusion
Rosuvastatin 5 mg is a potent and well-tolerated statin that effectively lowers LDL-C and improves overall lipid profiles in diverse patient groups. It often outperforms comparable doses of other statins and is effective even in patients who are intolerant to other statin regimens. For many patients, especially those at high cardiovascular risk or with diabetes, rosuvastatin 5 mg provides a strong option for achieving lipid-lowering goals with a favorable safety profile.
Sources and full results
Most relevant research papers on this topic